Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress PR Newswire - Thu Jun 18, 6:00AM CDT

HOLON, Israel , June 18, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 2.39 (-3.24%)
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 PR Newswire - Thu Jun 11, 6:00AM CDT

HOLON, Israel , June 11, 2026 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target discovery...

CGEN : 2.39 (-3.24%)
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development PR Newswire - Mon Jun 8, 6:00AM CDT

HOLON, Israel , June 8, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by...

CGEN : 2.39 (-3.24%)
MarketBeat.com
Compugen Q1 Earnings Call Highlights MarketBeat - Mon May 18, 9:08AM CDT

Compugen (NASDAQ:CGEN) said it remains on track to report interim progression-free survival data in the first quarter of 2027 from its MAIA-ovarian study, as the clinical-stage immuno-oncology company...

CGEN : 2.39 (-3.24%)
Compugen: Q1 Earnings Snapshot AP - Mon May 18, 6:58AM CDT

Compugen: Q1 Earnings Snapshot

CGEN : 2.39 (-3.24%)
Compugen Reports First Quarter 2026 Results PR Newswire - Mon May 18, 6:00AM CDT

HOLON, Israel , May 18, 2026 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered...

CGEN : 2.39 (-3.24%)
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum PR Newswire - Tue May 12, 6:00AM CDT

HOLON, Israel , May 12, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by...

CGEN : 2.39 (-3.24%)
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026 PR Newswire - Mon May 4, 6:00AM CDT

HOLON, Israel , May 4, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 2.39 (-3.24%)
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference PR Newswire - Thu Apr 9, 6:00AM CDT

HOLON, Israel , April 9, 2026 /PRNewswire/ --  Compugen Ltd.  (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced...

CGEN : 2.39 (-3.24%)
Compugen: Q4 Earnings Snapshot AP - Mon Mar 2, 6:17AM CST

Compugen: Q4 Earnings Snapshot

CGEN : 2.39 (-3.24%)

Barchart Exclusives

Apple vs. Nvidia: One Is Growing 10x Faster and Trades Cheaper. The Better AI Dividend Stock Is Clear. Barchart - Fri Jul 10, 6:00PM CDT
Apple offers stability through its ecosystem, while NVIDIA leads AI growth. Which tech giant offers the better opportunity today? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.